Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21118657 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed N-acetylcysteine (NAC) for Improving Cognitive Dysfunction in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: N-acetylcysteine (NAC);   Drug: Inactive placebo capsule

Study has passed its completion date and status has not been verified in more than two years.